Massachusetts Financial Services’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.8K | Sell |
16,922
-230,899
| -93% | -$556K | ﹤0.01% | 884 |
|
|
2025
Q1 | $548K | Sell |
247,821
-4,416,389
| -95% | -$9.76M | ﹤0.01% | 844 |
|
|
2024
Q4 | $25.4M | Buy |
4,664,210
+1,062,485
| +29% | +$5.79M | 0.01% | 571 |
|
|
2024
Q3 | $29.9M | Sell |
3,601,725
-948,778
| -21% | -$7.88M | 0.01% | 537 |
|
|
2024
Q2 | $32.6M | Buy |
4,550,503
+598,530
| +15% | +$4.29M | 0.01% | 523 |
|
|
2024
Q1 | $34.3M | Sell |
3,951,973
-2,062,602
| -34% | -$17.9M | 0.01% | 512 |
|
|
2023
Q4 | $39.4M | Sell |
6,014,575
-2,138,905
| -26% | -$14M | 0.01% | 486 |
|
|
2023
Q3 | $81.5M | Sell |
8,153,480
-3,000,776
| -27% | -$30M | 0.03% | 380 |
|
|
2023
Q2 | $139M | Sell |
11,154,256
-603,231
| -5% | -$7.5M | 0.05% | 311 |
|
|
2023
Q1 | $165M | Sell |
11,757,487
-1,290,473
| -10% | -$18.1M | 0.06% | 270 |
|
|
2022
Q4 | $187M | Sell |
13,047,960
-1,102,931
| -8% | -$15.8M | 0.07% | 247 |
|
|
2022
Q3 | $361M | Buy |
14,150,891
+1,459,720
| +12% | +$37.3M | 0.14% | 168 |
|
|
2022
Q2 | $361M | Buy |
12,691,171
+3,726,068
| +42% | +$106M | 0.12% | 172 |
|
|
2022
Q1 | $316M | Buy |
8,965,103
+962,082
| +12% | +$33.9M | 0.09% | 196 |
|
|
2021
Q4 | $335M | Buy |
8,003,021
+2,459,692
| +44% | +$103M | 0.09% | 194 |
|
|
2021
Q3 | $272M | Buy |
5,543,329
+523,916
| +10% | +$25.7M | 0.08% | 213 |
|
|
2021
Q2 | $209M | Sell |
5,019,413
-363,705
| -7% | -$15.2M | 0.06% | 255 |
|
|
2021
Q1 | $192M | Buy |
5,383,118
+1,146,511
| +27% | +$40.9M | 0.06% | 267 |
|
|
2020
Q4 | $119M | Buy |
+4,236,607
| New | +$119M | 0.04% | 337 |
|